# Proteomic Approach to Study the Effect of Pneumocystis jirovecii Colonization in Idiopathic Pulmonary Fibrosis

**Authors:** Jonás Carmona-Pírez, Rocío Salsoso, Eléna Charpentier, Cinta Olmedo, Francisco J. Medrano, Lucas Román, Carmen de la Horra, Yaxsier de Armas, Enrique J. Calderón, Vicente Friaza

PMC · DOI: 10.3390/jof11020102 · 2025-01-29

## TL;DR

This study uses proteomics to explore how Pneumocystis jirovecii colonization affects the progression of idiopathic pulmonary fibrosis.

## Contribution

This is the first study to analyze the proteomic impact of Pneumocystis jirovecii colonization in idiopathic pulmonary fibrosis patients.

## Key findings

- 92 differentially expressed proteins were identified, with vimentin being a key protein.
- Glycolysis pathway was highlighted in PJ-colonized IPF patients.
- JAK-STAT signaling complex was found in non-colonized IPF patients.

## Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and interstitial disease with an unclear cause, believed to involve genetic, environmental, and molecular factors. Recent research suggested that Pneumocystis jirovecii (PJ) could contribute to disease exacerbations and severity. This article explores how PJ colonization might influence the pathogenesis of IPF. We performed a proteomic analysis to study the profile of control and IPF patients, with/without PJ. We recruited nine participants from the Virgen del Rocio University Hospital (Seville, Spain). iTRAQ and bioinformatics analyses were performed to identify differentially expressed proteins (DEPs), including a functional analysis of DEPs and of the protein–protein interaction networks built using the STRING database. We identified a total of 92 DEPs highlighting the protein vimentin when comparing groups. Functional differences were observed, with the glycolysis pathway highlighted in PJ-colonized IPF patients; as well as the pentose phosphate pathway and miR-133A in non-colonized IPF patients. We found 11 protein complexes, notably the JAK-STAT signaling complex in non-colonized IPF patients. To our knowledge, this is the first study that analyzed PJ colonization’s effect on IPF patients. However, further research is needed, especially on the complex interactions with the AKT/GSK-3β/snail pathway that could explain some of our results.

## Linked entities

- **Proteins:** PRELID1 (PRELI domain containing 1), MIR133A (microRNA mir-133a)
- **Diseases:** idiopathic pulmonary fibrosis (MONDO:0800029)
- **Species:** Pneumocystis jirovecii (taxon 42068)

## Full-text entities

- **Genes:** VIM (vimentin) [NCBI Gene 7431], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, SNAI1 (snail family transcriptional repressor 1) [NCBI Gene 6615] {aka SLUGH2, SNA, SNAH, SNAIL, SNAIL1, dJ710H13.1}, GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 2932]
- **Diseases:** IPF (MESH:D054990), interstitial disease (MESH:D017563)
- **Chemicals:** pentose phosphate (MESH:D010428)
- **Species:** Pneumocystis jirovecii (species) [taxon 42068], Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11857022/full.md

---
Source: https://tomesphere.com/paper/PMC11857022